Crossmark

Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease

Crossref DOI link: https://doi.org/10.1152/ajprenal.00154.2021

Published Print: 2021-08-01

Update policy: https://doi.org/10.1152/aps-crossmark-policy

Authors

Østergaard, Mette V. https://orcid.org/0000-0001-6075-2392
Secher, Thomas

Christensen, Michael

Salinas, Casper Gravesen

Roostalu, Urmas

Skytte, Jacob Lercke

Rune, Ida

Hansen, Henrik H. https://orcid.org/0000-0002-3732-0281
Jelsing, Jacob

Vrang, Niels

Fink, Lisbeth N.
More Information

Publication History

Received: 2021-04-16

Accepted: 2021-06-16

Published: 2021-07-27